Will differentiation of Daewoong Pharmaceutical be magnified in the Baraclude market?

Daewoong Pharmaceutical will challenge to the type B liver cancer treatment.

According to the industry concerned, Daewoong Pharmaceutical and CTC Bio have been approved for generic products of Baraclude(BMS).

The products of the two companies are unique among their competing products as they are film-type products.

First of all, Daewoong Pharmaceutical owns Baracross Film 0.5mg and 1mg, and ...